Sequence of CDK2_HUMAN

cyclin-dependent kinase

P24941

298

33930

908653

Elledge S.J.,Spottswood M.R.

A new human p34 protein kinase, CDK2, identified by complementation of a cdc28 mutation in Saccharomyces cerevisiae, is a homolog of Xenopus Eg1.

EMBO J.

10

2653-2659

1991

908654

Tsai L.-H.,Harlow E.,Meyerson M.

Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase.

Nature

353

174-177

1991

908655

Ninomiya-Tsuji J.,Nomoto S.,Yasuda H.,Reed S.I.,Matsumoto K.

Cloning of a human cDNA encoding a CDC2-related kinase by complementation of a budding yeast cdc28 mutation.

Proc. Natl. Acad. Sci. U.S.A.

88

9006-9010

1991

908659

Ota T.,Suzuki Y.,Nishikawa T.,Otsuki T.,Sugiyama T.,Irie R.,Wakamatsu A.,Hayashi K.,Sato H.,Nagai K.,Kimura K.,Makita H.,Sekine M.,Obayashi M.,Nishi T.,Shibahara T.,Tanaka T.,Ishii S.,Yamamoto J.,Saito K.,Kawai Y.,Isono Y.,Nakamura Y.,Nagahari K.,Murakami K.,Yasuda T.,Iwayanagi T.,Wagatsuma M.,Shiratori A.,Sudo H.,Hosoiri T.,Kaku Y.,Kodaira H.,Kondo H.,Sugawara M.,Takahashi M.,Kanda K.,Yokoi T.,Furuya T.,Kikkawa E.,Omura Y.,Abe K.,Kamihara K.,Katsuta N.,Sato K.,Tanikawa M.,Yamazaki M.,Ninomiya K.,Ishibashi T.,Yamashita H.,Murakawa K.,Fujimori K.,Tanai H.,Kimata M.,Watanabe M.,Hiraoka S.,Chiba Y.,Ishida S.,Ono Y.,Takiguchi S.,Watanabe S.,Yosida M.,Hotuta T.,Kusano J.,Kanehori K.,Takahashi-Fujii A.,Hara H.,Tanase T.-O.,Nomura Y.,Togiya S.,Komai F.,Hara R.,Takeuchi K.,Arita M.,Imose N.,Musashino K.,Yuuki H.,Oshima A.,Sasaki N.,Aotsuka S.,Yoshikawa Y.,Matsunawa H.,Ichihara T.,Shiohata N.,Sano S.,Moriya S.,Momiyama H.,Satoh N.,Takami S.,Terashima Y.,Suzuki O.,Nakagawa S.,Senoh A.,Mizoguchi H.,Goto Y.,Shimizu F.,Wakebe H.,Hishigaki H.,Watanabe T.,Sugiyama A.,Takemoto M.,Kawakami B.,Yamazaki M.,Watanabe K.,Kumagai A.,Itakura S.,Fukuzumi Y.,Fujimori Y.,Komiyama M.,Tashiro H.,Tanigami A.,Fujiwara T.,Ono T.,Yamada K.,Fujii Y.,Ozaki K.,Hirao M.,Ohmori Y.,Kawabata A.,Hikiji T.,Kobatake N.,Inagaki H.,Ikema Y.,Okamoto S.,Okitani R.,Kawakami T.,Noguchi S.,Itoh T.,Shigeta K.,Senba T.,Matsumura K.,Nakajima Y.,Mizuno T.,Morinaga M.,Sasaki M.,Togashi T.,Oyama M.,Hata H.,Watanabe M.,Komatsu T.,Mizushima-Sugano J.,Satoh T.,Shirai Y.,Takahashi Y.,Nakagawa K.,Okumura K.,Nagase T.,Nomura N.,Kikuchi H.,Masuho Y.,Yamashita R.,Nakai K.,Yada T.,Nakamura Y.,Ohara O.,Isogai T.,Sugano S.

Complete sequencing and characterization of 21,243 full-length human cDNAs.

Nat. Genet.

36

40-45

2004

908660

Scherer S.E.,Muzny D.M.,Buhay C.J.,Chen R.,Cree A.,Ding Y.,Dugan-Rocha S.,Gill R.,Gunaratne P.,Harris R.A.,Hawes A.C.,Hernandez J.,Hodgson A.V.,Hume J.,Jackson A.,Khan Z.M.,Kovar-Smith C.,Lewis L.R.,Lozado R.J.,Metzker M.L.,Milosavljevic A.,Miner G.R.,Montgomery K.T.,Morgan M.B.,Nazareth L.V.,Scott G.,Sodergren E.,Song X.-Z.,Steffen D.,Lovering R.C.,Wheeler D.A.,Worley K.C.,Yuan Y.,Zhang Z.,Adams C.Q.,Ansari-Lari M.A.,Ayele M.,Brown M.J.,Chen G.,Chen Z.,Clerc-Blankenburg K.P.,Davis C.,Delgado O.,Dinh H.H.,Draper H.,Gonzalez-Garay M.L.,Havlak P.,Jackson L.R.,Jacob L.S.,Kelly S.H.,Li L.,Li Z.,Liu J.,Liu W.,Lu J.,Maheshwari M.,Nguyen B.-V.,Okwuonu G.O.,Pasternak S.,Perez L.M.,Plopper F.J.H.,Santibanez J.,Shen H.,Tabor P.E.,Verduzco D.,Waldron L.,Wang Q.,Williams G.A.,Zhang J.,Zhou J.,Allen C.C.,Amin A.G.,Anyalebechi V.,Bailey M.,Barbaria J.A.,Bimage K.E.,Bryant N.P.,Burch P.E.,Burkett C.E.,Burrell K.L.,Calderon E.,Cardenas V.,Carter K.,Casias K.,Cavazos I.,Cavazos S.R.,Ceasar H.,Chacko J.,Chan S.N.,Chavez D.,Christopoulos C.,Chu J.,Cockrell R.,Cox C.D.,Dang M.,Dathorne S.R.,David R.,Davis C.M.,Davy-Carroll L.,Deshazo D.R.,Donlin J.E.,D'Souza L.,Eaves K.A.,Egan A.,Emery-Cohen A.J.,Escotto M.,Flagg N.,Forbes L.D.,Gabisi A.M.,Garza M.,Hamilton C.,Henderson N.,Hernandez O.,Hines S.,Hogues M.E.,Huang M.,Idlebird D.G.,Johnson R.,Jolivet A.,Jones S.,Kagan R.,King L.M.,Leal B.,Lebow H.,Lee S.,LeVan J.M.,Lewis L.C.,London P.,Lorensuhewa L.M.,Loulseged H.,Lovett D.A.,Lucier A.,Lucier R.L.,Ma J.,Madu R.C.,Mapua P.,Martindale A.D.,Martinez E.,Massey E.,Mawhiney S.,Meador M.G.,Mendez S.,Mercado C.,Mercado I.C.,Merritt C.E.,Miner Z.L.,Minja E.,Mitchell T.,Mohabbat F.,Mohabbat K.,Montgomery B.,Moore N.,Morris S.,Munidasa M.,Ngo R.N.,Nguyen N.B.,Nickerson E.,Nwaokelemeh O.O.,Nwokenkwo S.,Obregon M.,Oguh M.,Oragunye N.,Oviedo R.J.,Parish B.J.,Parker D.N.,Parrish J.,Parks K.L.,Paul H.A.,Payton B.A.,Perez A.,Perrin W.,Pickens A.,Primus E.L.,Pu L.-L.,Puazo M.,Quiles M.M.,Quiroz J.B.,Rabata D.,Reeves K.,Ruiz S.J.,Shao H.,Sisson I.,Sonaike T.,Sorelle R.P.,Sutton A.E.,Svatek A.F.,Svetz L.A.,Tamerisa K.S.,Taylor T.R.,Teague B.,Thomas N.,Thorn R.D.,Trejos Z.Y.,Trevino B.K.,Ukegbu O.N.,Urban J.B.,Vasquez L.I.,Vera V.A.,Villasana D.M.,Wang L.,Ward-Moore S.,Warren J.T.,Wei X.,White F.,Williamson A.L.,Wleczyk R.,Wooden H.S.,Wooden S.H.,Yen J.,Yoon L.,Yoon V.,Zorrilla S.E.,Nelson D.,Kucherlapati R.,Weinstock G.,Gibbs R.A.

The finished DNA sequence of human chromosome 12.

Nature

440

346-351

2006

908662

The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

Genome Res.

14

2121-2127

2004

908663

Gu Y.,Rosenblatt J.,O'Morgan D.O.

Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.

EMBO J.

11

3995-4005

1992

908664

Meijer L.,Borgne A.,Mulner O.,Chong J.P.J.,Blow J.J.,Inagaki N.,Inagaki M.,Delcros J.-G.,Moulinoux J.-P.

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

Eur. J. Biochem.

243

527-536

1997

908665

Harbour J.W.,Luo R.X.,Dei Santi A.,Postigo A.A.,Dean D.C.

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1.

Cell

98

859-869

1999

908666

Okuda M.,Horn H.F.,Tarapore P.,Tokuyama Y.,Smulian A.G.,Chan P.K.,Knudsen E.S.,Hofmann I.A.,Snyder J.D.,Bove K.E.,Fukasawa K.

Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication.

Cell

103

127-140

2000

908667

Zhao J.,Kennedy B.K.,Lawrence B.D.,Barbie D.A.,Matera A.G.,Fletcher J.A.,Harlow E.

NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription.

Genes Dev.

14

2283-2297

2000

908668

Ma T.,Van Tine B.A.,Wei Y.,Garrett M.D.,Nelson D.,Adams P.D.,Wang J.,Qin J.,Chow L.T.,Harper J.W.

Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription.

Genes Dev.

14

2298-2313

2000

908669

Luciani M.G.,Hutchins J.R.A.,Zheleva D.,Hupp T.R.

The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.

J. Mol. Biol.

300

503-518

2000

908670

Garrett S.,Barton W.A.,Knights R.,Jin P.,Morgan D.O.,Fisher R.P.

Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.

Mol. Cell. Biol.

21

88-99

2001

908671

Nguyen T.B.,Manova K.,Capodieci P.,Lindon C.,Bottega S.,Wang X.-Y.,Refik-Rogers J.,Pines J.,Wolgemuth D.J.,Koff A.

Characterization and expression of mammalian cyclin b3, a prepachytene meiotic cyclin.

J. Biol. Chem.

277

41960-41969

2002

908672

Porter L.A.,Dellinger R.W.,Tynan J.A.,Barnes E.A.,Kong M.,Lenormand J.-L.,Donoghue D.J.

Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.

J. Cell Biol.

157

357-366

2002

908673

Barnes E.A.,Porter L.A.,Lenormand J.-L.,Dellinger R.W.,Donoghue D.J.

Human Spy1 promotes survival of mammalian cells following DNA damage.

Cancer Res.

63

3701-3707

2003

908674

Terret M.E.,Lefebvre C.,Djiane A.,Rassinier P.,Moreau J.,Maro B.,Verlhac M.H.

DOC1R: a MAP kinase substrate that control microtubule organization of metaphase II mouse oocytes.

Development

130

5169-5177

2003

908675

Porter L.A.,Kong-Beltran M.,Donoghue D.J.

Spy1 interacts with p27Kip1 to allow G1/S progression.

Mol. Biol. Cell

14

3664-3674

2003

908676

Li Y.,Mori T.,Hata H.,Homma Y.,Kochi H.

NIRF induces G1 arrest and associates with Cdk2.

Biochem. Biophys. Res. Commun.

319

464-468

2004

908677

Wang G.L.,Iakova P.,Wilde M.,Awad S.,Timchenko N.A.

Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity.

Genes Dev.

18

912-925

2004

908678

Liu Y.,Wu C.,Galaktionov K.

p42, a novel cyclin-dependent kinase-activating kinase in mammalian cells.

J. Biol. Chem.

279

4507-4514

2004

908679

Cheng A.,Xiong W.,Ferrell J.E. Jr.,Solomon M.J.

Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins.

Cell Cycle

4

155-165

2005

908680

Esashi F.,Christ N.,Gannon J.,Liu Y.,Hunt T.,Jasin M.,West S.C.

CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair.

Nature

434

598-604

2005

908681

Lolli G.,Johnson L.N.

Recognition of Cdk2 by Cdk7.

Proteins

67

1048-1059

2007

908682

Daub H.,Olsen J.V.,Bairlein M.,Gnad F.,Oppermann F.S.,Korner R.,Greff Z.,Keri G.,Stemmann O.,Mann M.

Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.

Mol. Cell

31

438-448

2008

908683

De Boer L.,Oakes V.,Beamish H.,Giles N.,Stevens F.,Somodevilla-Torres M.,Desouza C.,Gabrielli B.

Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events.

Oncogene

27

4261-4268

2008

908684

Kong Y.,Nan K.,Yin Y.

Identification and characterization of CAC1 as a novel CDK2-associated cullin.

Cell Cycle

8

3552-3561

2009

908685

Oppermann F.S.,Gnad F.,Olsen J.V.,Hornberger R.,Greff Z.,Keri G.,Mann M.,Daub H.

Large-scale proteomics analysis of the human kinome.

Mol. Cell. Proteomics

8

1751-1764

2009

908686

Mayya V.,Lundgren D.H.,Hwang S.-I.,Rezaul K.,Wu L.,Eng J.K.,Rodionov V.,Han D.K.

Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

Sci. Signal.

2

0-0

2009

908687

Choudhary C.,Kumar C.,Gnad F.,Nielsen M.L.,Rehman M.,Walther T.C.,Olsen J.V.,Mann M.

Lysine acetylation targets protein complexes and co-regulates major cellular functions.

Science

325

834-840

2009

908688

Flores O.,Wang Z.,Knudsen K.E.,Burnstein K.L.

Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition.

Endocrinology

151

896-908

2010

908689

Kumar S.,Barthwal M.K.,Dikshit M.

Cdk2 nitrosylation and loss of mitochondrial potential mediate NO-dependent biphasic effect on HL-60 cell cycle.

Free Radic. Biol. Med.

48

851-861

2010

908690

Timofeev O.,Cizmecioglu O.,Settele F.,Kempf T.,Hoffmann I.

Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition.

J. Biol. Chem.

285

16978-16990

2010

908691

Chen S.,Bohrer L.R.,Rai A.N.,Pan Y.,Gan L.,Zhou X.,Bagchi A.,Simon J.A.,Huang H.

Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2.

Nat. Cell Biol.

12

1108-1114

2010

908692

Chung J.H.,Bunz F.

Cdk2 is required for p53-independent G2/M checkpoint control.

PLoS Genet.

6

0-0

2010

908693

Hydbring P.,Bahram F.,Su Y.,Tronnersjoe S.,Hoegstrand K.,von der Lehr N.,Sharifi H.R.,Lilischkis R.,Hein N.,Wu S.,Vervoorts J.,Henriksson M.,Grandien A.,Luescher B.,Larsson L.-G.

Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.

Proc. Natl. Acad. Sci. U.S.A.

107

58-63

2010

908694

Burkard T.R.,Planyavsky M.,Kaupe I.,Breitwieser F.P.,Buerckstuemmer T.,Bennett K.L.,Superti-Furga G.,Colinge J.

Initial characterization of the human central proteome.

BMC Syst. Biol.

5

17-17

2011

908695

Loffler H.,Fechter A.,Matuszewska M.,Saffrich R.,Mistrik M.,Marhold J.,Hornung C.,Westermann F.,Bartek J.,Kramer A.

Cep63 recruits Cdk1 to the centrosome: implications for regulation of mitotic entry, centrosome amplification, and genome maintenance.

Cancer Res.

71

2129-2139

2011

908696

Fiset A.,Xu E.,Bergeron S.,Marette A.,Pelletier G.,Siminovitch K.A.,Olivier M.,Beauchemin N.,Faure R.L.

Compartmentalized CDK2 is connected with SHP-1 and beta-catenin and regulates insulin internalization.

Cell. Signal.

23

911-919

2011

908697

Lee J.,Kim K.H.,Jeong S.

Discovery of a novel class of 2-aminopyrimidines as CDK1 and CDK2 inhibitors.

Bioorg. Med. Chem. Lett.

21

4203-4205

2011

908698

Huang X.,Summers M.K.,Pham V.,Lill J.R.,Liu J.,Lee G.,Kirkpatrick D.S.,Jackson P.K.,Fang G.,Dixit V.M.

Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry.

Mol. Cell

42

511-523

2011

908699

Neganova I.,Vilella F.,Atkinson S.P.,Lloret M.,Passos J.F.,von Zglinicki T.,O'Connor J.-E.,Burks D.,Jones R.,Armstrong L.,Lako M.

An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.

Stem Cells

29

651-659

2011

908700

Satyanarayana A.,Kaldis P.

A dual role of Cdk2 in DNA damage response.

Cell Div.

4

9-9

2009

908701

Malumbres M.,Barbacid M.

Cell cycle, CDKs and cancer: a changing paradigm.

Nat. Rev. Cancer

9

153-166

2009

908702

Satyanarayana A.,Kaldis P.

Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.

Oncogene

28

2925-2939

2009

908703

Hydbring P.,Larsson L.-G.

Tipping the balance: Cdk2 enables Myc to suppress senescence.

Cancer Res.

70

6687-6691

2010

908704

Wang Q.,Su L.,Liu N.,Zhang L.,Xu W.,Fang H.

Cyclin dependent kinase 1 inhibitors: a review of recent progress.

Curr. Med. Chem.

18

2025-2043

2011

908705

Van Damme P.,Lasa M.,Polevoda B.,Gazquez C.,Elosegui-Artola A.,Kim D.S.,De Juan-Pardo E.,Demeyer K.,Hole K.,Larrea E.,Timmerman E.,Prieto J.,Arnesen T.,Sherman F.,Gevaert K.,Aldabe R.

N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

Proc. Natl. Acad. Sci. U.S.A.

109

12449-12454

2012

908706

Liu Q.,Liu X.,Gao J.,Shi X.,Hu X.,Wang S.,Luo Y.

Overexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activation.

Int. J. Biol. Sci.

9

541-549

2013

908707

Batenburg N.L.,Walker J.R.,Noordermeer S.M.,Moatti N.,Durocher D.,Zhu X.D.

ATM and CDK2 control chromatin remodeler CSB to inhibit RIF1 in DSB repair pathway choice.

Nat. Commun.

8

1921-1921

2017

908708

de Bondt H.L.,Rosenblatt J.,Jancarik J.,Jones H.D.,Morgan D.O.,Kim S.-H.

Crystal structure of cyclin-dependent kinase 2.

Nature

363

595-602

1993

908709

Jeffrey P.D.,Russo A.A.,Polyak K.,Gibbs E.,Hurwitz J.,Massague J.,Pavletich N.P.

Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.

Nature

376

313-320

1995

908710

Bourne Y.,Watson M.H.,Hickey M.J.,Holmes W.,Rocque W.,Reed S.I.,Tainer J.A.

Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1.

Cell

84

863-874

1996

908711

Schulze-Gahmen U.,de Bondt H.L.,Kim S.-H.

High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design.

J. Med. Chem.

39

4540-4546

1996

908712

Russo A.A.,Jeffrey P.D.,Patten A.K.,Massague J.,Pavletich N.P.

Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.

Nature

382

325-331

1996

908713

Russo A.A.,Jeffrey P.D.,Pavletich N.P.

Structural basis of cyclin-dependent kinase activation by phosphorylation.

Nat. Struct. Biol.

3

696-700

1996

908714

de Azevedo W.F. Jr.,Mueller-Dieckmann H.-J.,Schulze-Gahmen U.,Worland P.J.,Sausville E.,Kim S.-H.

Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.

Proc. Natl. Acad. Sci. U.S.A.

93

2735-2740

1996

908715

Lawrie A.M.,Noble M.E.M.,Tunnah P.,Brown N.R.,Johnson L.N.,Endicott J.A.

Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2.

Nat. Struct. Biol.

4

796-801

1997

908716

Gray N.S.,Wodicka L.,Thunnissen A.-M.W.H.,Norman T.C.,Kwon S.,Espinoza F.H.,Morgan D.O.,Barnes G.,Leclerc S.,Meijer L.,Kim S.H.,Lockhart D.J.,Schultz P.G.

Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.

Science

281

533-538

1998

908717

Richardson C.M.,Williamson D.S.,Parratt M.J.,Borgognoni J.,Cansfield A.D.,Dokurno P.,Francis G.L.,Howes R.,Moore J.D.,Murray J.B.,Robertson A.,Surgenor A.E.,Torrance C.J.

Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR.

Bioorg. Med. Chem. Lett.

16

1353-1357

2006

908718

Richardson C.M.,Nunns C.L.,Williamson D.S.,Parratt M.J.,Dokurno P.,Howes R.,Borgognoni J.,Drysdale M.J.,Finch H.,Hubbard R.E.,Jackson P.S.,Kierstan P.,Lentzen G.,Moore J.D.,Murray J.B.,Simmonite H.,Surgenor A.E.,Torrance C.J.

Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scoping.

Bioorg. Med. Chem. Lett.

17

3880-3885

2007

908719

Brown N.R.,Lowe E.D.,Petri E.,Skamnaki V.,Antrobus R.,Johnson L.N.

Cyclin B and cyclin A confer different substrate recognition properties on CDK2.

Cell Cycle

6

1350-1359

2007

908720

Welburn J.P.I.,Tucker J.A.,Johnson T.,Lindert L.,Morgan M.,Willis A.,Noble M.E.M.,Endicott J.A.

How tyrosine 15 phosphorylation inhibits the activity of cyclin-dependent kinase 2-cyclin A.

J. Biol. Chem.

282

3173-3181

2007

908721

Fischmann T.O.,Hruza A.,Duca J.S.,Ramanathan L.,Mayhood T.,Windsor W.T.,Le H.V.,Guzi T.J.,Dwyer M.P.,Paruch K.,Doll R.J.,Lees E.,Parry D.,Seghezzi W.,Madison V.

Structure-guided discovery of cyclin-dependent kinase inhibitors.

Biopolymers

89

372-379

2008

908722

Wyatt P.G.,Woodhead A.J.,Berdini V.,Boulstridge J.A.,Carr M.G.,Cross D.M.,Davis D.J.,Devine L.A.,Early T.R.,Feltell R.E.,Lewis E.J.,McMenamin R.L.,Navarro E.F.,O'Brien M.A.,O'Reilly M.,Reule M.,Saxty G.,Seavers L.C.,Smith D.M.,Squires M.S.,Trewartha G.,Walker M.T.,Woolford A.J.

Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design.

J. Med. Chem.

51

4986-4999

2008

908723

Bao Z.Q.,Jacobsen D.M.,Young M.A.

Briefly bound to activate: transient binding of a second catalytic magnesium activates the structure and dynamics of CDK2 kinase for catalysis.

Structure

19

675-690

2011

908724

McGrath D.A.,Fifield B.A.,Marceau A.H.,Tripathi S.,Porter L.A.,Rubin S.M.

Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.

EMBO J.

36

2251-2262

2017

908725

Greenman C.,Stephens P.,Smith R.,Dalgliesh G.L.,Hunter C.,Bignell G.,Davies H.,Teague J.,Butler A.,Stevens C.,Edkins S.,O'Meara S.,Vastrik I.,Schmidt E.E.,Avis T.,Barthorpe S.,Bhamra G.,Buck G.,Choudhury B.,Clements J.,Cole J.,Dicks E.,Forbes S.,Gray K.,Halliday K.,Harrison R.,Hills K.,Hinton J.,Jenkinson A.,Jones D.,Menzies A.,Mironenko T.,Perry J.,Raine K.,Richardson D.,Shepherd R.,Small A.,Tofts C.,Varian J.,Webb T.,West S.,Widaa S.,Yates A.,Cahill D.P.,Louis D.N.,Goldstraw P.,Nicholson A.G.,Brasseur F.,Looijenga L.,Weber B.L.,Chiew Y.-E.,DeFazio A.,Greaves M.F.,Green A.R.,Campbell P.,Birney E.,Easton D.F.,Chenevix-Trench G.,Tan M.-H.,Khoo S.K.,Teh B.T.,Yuen S.T.,Leung S.Y.,Wooster R.,Futreal P.A.,Stratton M.R.

Patterns of somatic mutation in human cancer genomes.

Nature

446

153-158

2007

908726

Menning M.,Kufer T.A.

A role for the Ankyrin repeat containing protein Ankrd17 in Nod1- and Nod2-mediated inflammatory responses.

FEBS Lett.

587

2137-2142

2013